SANUWAVE Health, Inc.
SNWV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.66 | 0.17 | 0.04 |
| FCF Yield | 0.17% | -0.06% | -0.56% | 0.57% |
| EV / EBITDA | 27.16 | 93.18 | -90.34 | -10.66 |
| Quality | ||||
| ROIC | 6.72% | 13.89% | 9.97% | 19.28% |
| Gross Margin | 76.00% | 78.30% | 79.04% | 77.87% |
| Cash Conversion Ratio | 0.10 | 0.94 | 0.27 | -0.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 29.74% | 29.33% | 27.84% | 24.91% |
| Free Cash Flow Growth | 434.94% | 90.11% | -432.48% | -59.08% |
| Safety | ||||
| Net Debt / EBITDA | 1.20 | 6.03 | -5.17 | -1.58 |
| Interest Coverage | 0.85 | 1.00 | 0.53 | 0.96 |
| Efficiency | ||||
| Inventory Turnover | 0.40 | 0.37 | 0.36 | 0.55 |
| Cash Conversion Cycle | 128.73 | 111.96 | 97.28 | 45.60 |